Concepedia

Bariki Mtafya

BM

22

Publications

1.7K

Citations

18

H-Index

2011

Active since

Affiliations

National Institute for Medical Research(Current)

Ludwig-Maximilians-Universität München

German Center for Infection Research

University of St Andrews

University College London

Bariki Mtafya is an author at National Institute for Medical Research specializing in tuberculosis, medical laboratory science, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

2011–2025

22

Publications

22

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 379 citations · Full text

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny Peter, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2016 · 262 citations

, , +12

Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study

Andrea Rachow, Alimuddin Zumla, Norbert Heinrich et al. · PLoS ONE · 2011 · 161 citations · Full text

Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study

Andrea Rachow, Petra Clowes, Elmar Saathoff et al. · Clinical Infectious Diseases · 2012 · 142 citations · Full text

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

Norbert Heinrich, Rodney Dawson, Jeannine du Bois et al. · Journal of Antimicrobial Chemotherapy · 2015 · 91 citations · Full text

Rows per page

1–5 of 22